Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
18.65
-0.03 (-0.16%)
At close: Nov 14, 2025, 4:00 PM EST
18.66
+0.01 (0.05%)
After-hours: Nov 14, 2025, 4:40 PM EST
Sabra Health Care REIT Stock Forecast
Stock Price Forecast
The 8 analysts that cover Sabra Health Care REIT stock have a consensus rating of "Hold" and an average price target of $20.5, which forecasts a 9.92% increase in the stock price over the next year. The lowest target is $20 and the highest is $22.
Price Target: $20.5 (+9.92%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Sabra Health Care REIT stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 3 | 3 | 4 | 4 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $21 → $20 | Buy | Maintains | $21 → $20 | +7.24% | Oct 21, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Initiates $20 | Hold | Initiates | $20 | +7.24% | Oct 1, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $18 → $20 | Hold | Maintains | $18 → $20 | +7.24% | Sep 3, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $20 → $21 | Buy | Maintains | $20 → $21 | +12.60% | Aug 27, 2025 |
| BMO Capital | BMO Capital | Hold Maintains $19 → $22 | Hold | Maintains | $19 → $22 | +17.96% | Aug 25, 2025 |
Financial Forecast
Revenue This Year
757.06M
from 702.64M
Increased by 7.75%
Revenue Next Year
825.50M
from 757.06M
Increased by 9.04%
EPS This Year
0.78
from 0.54
Increased by 44.82%
EPS Next Year
0.80
from 0.78
Increased by 2.61%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 821.0M | 992.7M | |||
| Avg | 757.1M | 825.5M | |||
| Low | 692.7M | 721.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 16.8% | 31.1% | |||
| Avg | 7.7% | 9.0% | |||
| Low | -1.4% | -4.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.86 | 0.88 | |
| Avg | 0.78 | 0.80 | |
| Low | 0.69 | 0.74 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 59.4% | 12.8% | |
| Avg | 44.8% | 2.6% | |
| Low | 27.0% | -4.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.